Reduction of the Metabolic Syndrome in Navarra-Spain
- Conditions
- Metabolic SyndromeCardiovascular DiseaseObesityDiabetes
- Interventions
- Behavioral: CrononutritionBehavioral: American Heart Association
- Registration Number
- NCT01087086
- Lead Sponsor
- Clinica Universidad de Navarra, Universidad de Navarra
- Brief Summary
The purpose of this study is to determine whether a dietary pattern based on crononutrition and dietary training, together with dietary and psychological control, can reduce the body weight, improve the oxidative and inflammatory state in subjects with diagnosed metabolic syndrome features and can reduce the prevalence of the Metabolic syndrome in the population.
- Detailed Description
The dietary pattern that characterizes the present nutritional intervention study is based on personalized diet, by elaborating tailoring-diets for each subject regarding his energetic needs and assuring a high adherence to the Mediterranean Diet. Moreover, the diet to be performed will be a hyperproteic diet to guarantee a satiety effect and a lower recovery of the lost weight, in accordance with the results derived from the main European study about nutrition (DIOGENES). The glycemic index/load will be also controlled in the study diet. The increase of the antioxidant capacity of the diet will be increased by the intake of fruits, walnuts and virgin olive oil among other antioxidant containing foods.
The present initiative, based on the traditional diet, aims to integrate the main results obtained from diverse observational epidemiological studies and interventional studies in the dietary pattern of the present study. At the same time, the study will apply the concept of crononutrition by selecting and distributing the foods thorough the day according the physiological needs of each individual.
In addition to the quantitative and qualitative composition of the diet, the study will take into account other important factors such as the behavior habits regarding the food, the frequency of consumption, the size of the eating portions, the distribution of the portions along the day, the feeling of fullness, the eating speed and so on. The aforementioned factors have recently been shown to be related to the gain of weight.
Other non dietary factors, such as smoking habits, sedentary life, socio-economic level, will be also controlled in the present study. Moreover, the project will integrate the dietary support together with psychological support due to the fact that the state of mind has been shown to be associated with the MS in some scientific publications.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 109
- 35-70 years old
- Both sexes: Male and Female
- Metabolic Syndrome according to the IDF(2005)criteria:
Waist circumference cutoffs (male ≥94 cm or female ≥80 cm) plus any two of the following four factors:
- Fasting glucose ≥5.55 mmol/L or use of antidiabetic medication
- Systolic BP ≥130 mm Hg, diastolic BP ≥85 mm Hg, or use of antihypertensive medication
- Fasting triglycerides ≥1.7 mm/L; and HDL-C <1.0 mm/L in men and <1.3 mm/L in women or specific treatment for this lipid abnormality
- Recent follow-up of diets designed for weight loss
- Unstable weight in the past 3 months
- Alcoholic and drug dependence
- Hormonal treatment
- No stable pharmacological treatment
- Eating-disordered behaviors
- Severe physical or mental disability
- Pregnancy
- Terminal disease
- Institutionalization
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Crononutrition Crononutrition Dietary pattern: * Personalized diet * Caloric restriction (-30% Total energy intake) * High adherence to the Mediterranean Diet * Macronutrient distribution (30% Protein, 40% Carbohydrates and 30% Fat) * Low glycemic index/load * Increased antioxidant capacity of the diet American Heart Association American Heart Association Dietary pattern: * Personalized diet * Caloric diet (-30% Total energy intake) * Macronutrients distribution according to the American Heart Association (AHA) guidelines
- Primary Outcome Measures
Name Time Method Body fat One year Through this specific nutritional intervention program we will try to reduce the metabolic syndrome features such as waist circumference, body weight and adiposity.
To evaluate the body composition, bioimpedance, DEXA and anthropometry methodology will be used at the beginning and after two months of intervention.Lipid profile One year To evaluate lipid improvements the following measurements will be taking into account:
* Free fatty acids
* Total cholesterol
* HDL-cholesterol
* LDL-cholesterolGlucose Profile One year To evaluate glucose improvements the following measurements will be taking into account:
* Glucose
* Insulin
* HOMA
- Secondary Outcome Measures
Name Time Method Fatty Liver biomarkers / Non invasive liver scoring system. May 2016- January 2017 Measurements in fatty liver biomarkers:
Serum transaminases (AST \& ALT (U/L)), GGT (U/L) and CK18 (U/L) concentrations will be measured in a fasting state at the beginning, at 2 months and at the end of the intervention.
- A specificif Fatty Liver Index was calculated at the begining, at 2 months and at the end of the intervention.Inflammation state One year As secondary outcome some inflammatory markers will be analyzed:
* CRP
* IL-6
* TNF-alpha
* IL-18
* PAI-1
* HomocysteinEpigenetics April 2012-July 2014 * DNA methylation
* microRNAs expressionPeripheral neurotransmitters March-April 2013 * Dopamine
* Dopac
* Serotonin
* 5-Hydroxyindoleacetic acid
* NoradrenalineOxidative stress One year As secondary outcome some oxidative stress markers will be analyzed:
* MDA
* LDL-OX
* Total antioxidant capacity (TAC)Psychological tests January 2010-November 2011 * Beck Depression Inventory
* Stai Trait Anxiety Inventory
* Mood thermometer visual analogue scale
* Anxiety thermometer visual analogue scale
* NEO personality inventory-revised test
Trial Locations
- Locations (1)
University of Navarra
🇪🇸Pamplona, Navarra, Spain